Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.

Petta S, Wai-Sun Wong V, Bugianesi E, Fracanzani AL, Cammà C, Hiriart JB, Lai-Hung Wong G, Vergniol J, Wing-Hung Chan A, Giannetti A, Merrouche W, Lik-Yuen Chan H, Le-Bail B, Lombardi R, Guastella S, Craxì A, de Ledinghen V.

Am J Gastroenterol. 2019 Jun;114(6):916-928. doi: 10.14309/ajg.0000000000000153.

PMID:
31169533
2.

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.

Boursier J, Guillaume M, Leroy V, Irlès M, Roux M, Lannes A, Foucher J, Zuberbuhler F, Delabaudière C, Barthelon J, Michalak S, Hiriart JB, Peron JM, Gerster T, Le Bail B, Riou J, Hunault G, Merrouche W, Oberti F, Pelade L, Fouchard I, Bureau C, Calès P, de Ledinghen V.

J Hepatol. 2019 May 16. pii: S0168-8278(19)30284-3. doi: 10.1016/j.jhep.2019.04.020. [Epub ahead of print]

PMID:
31102719
3.

Repeat surgery in HNF1alpha-inactivated adenomatosis.

Balabaud C, Laurent C, Frulio N, Marie Christine SP, Le Bail B, Possenti L, Blanc JF, Chiche L, Bioulac-Sage P.

Clin Res Hepatol Gastroenterol. 2019 Mar 19. pii: S2210-7401(18)30257-2. doi: 10.1016/j.clinre.2018.11.001. [Epub ahead of print]

PMID:
30902584
4.

Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum.

Le Loarer F, Laffont S, Lesluyes T, Tirode F, Antonescu C, Baglin AC, Delespaul L, Soubeyran I, Hostein I, Pérot G, Chibon F, Baud J, Le Guellec S, Karanian M, Costes-Martineau V, Castain C, Eimer S, Le Bail B, Wassef M, Coindre JM.

Am J Surg Pathol. 2019 Jun;43(6):747-754. doi: 10.1097/PAS.0000000000001238.

PMID:
30829729
5.

Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False.

Desjardin M, Bonhomme B, Le Bail B, Evrard S, Brouste V, Desolneux G, Fonck M, Bécouarn Y, Béchade D.

Clin Med Insights Oncol. 2019 Jan 22;13:1179554918825450. doi: 10.1177/1179554918825450. eCollection 2019.

6.

Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.

Wong VW, Irles M, Wong GL, Shili S, Chan AW, Merrouche W, Shu SS, Foucher J, Le Bail B, Chan WK, Chan HL, de Ledinghen V.

Gut. 2019 Jan 18. pii: gutjnl-2018-317334. doi: 10.1136/gutjnl-2018-317334. [Epub ahead of print]

PMID:
30658997
7.

Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.

Bioulac-Sage P, Sempoux C, Frulio N, Le Bail B, Blanc JF, Castain C, Laurent C, Trillaud H, Chiche L, Balabaud C.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):12-19. doi: 10.1016/j.clinre.2018.07.007. Epub 2018 Sep 10.

PMID:
30213653
8.

Collision of hepatocellular nodules in vascular livers: A medical challenge.

Le Bail B, Chiche L, Balabaud C, Bioulac-Sage P.

Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):e83-e85. doi: 10.1016/j.clinre.2017.11.001. Epub 2018 Aug 23. No abstract available.

PMID:
30145279
9.

Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.

Boursier J, Cassinotto C, Hunault G, Shili S, Lebigot J, Lapuyade B, Lannes A, Hiriart JB, Cartier V, Le Bail B, Michalak S, Mouries A, Oberti F, Chermak F, Fouchard-Hubert I, Cales P, Aube C, de Ledinghen V.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):164-171.e5. doi: 10.1016/j.cgh.2018.04.062. Epub 2018 May 9.

PMID:
29753082
10.

MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.

Indersie E, Lesjean S, Hooks KB, Sagliocco F, Ernault T, Cairo S, Merched-Sauvage M, Rullier A, Le Bail B, Taque S, Grotzer M, Branchereau S, Guettier C, Fabre M, Brugières L, Hagedorn M, Buendia MA, Grosset CF.

Hepatol Commun. 2017 Apr 6;1(2):168-183. doi: 10.1002/hep4.1029. eCollection 2017 Apr.

11.

Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.

Balabaud C, Laurent C, Le Bail B, Castain C, Possenti L, Frulio N, Chiche L, Blanc JF, Bioulac-Sage P.

Liver Int. 2018 Jul;38(7):1273-1279. doi: 10.1111/liv.13667. Epub 2018 Jan 17.

PMID:
29265678
12.

Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.

Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Marra F, Le-Bail B, Arena U, Craxì A, de Ledinghen V.

Aliment Pharmacol Ther. 2017 Sep;46(6):617-627. doi: 10.1111/apt.14219. Epub 2017 Jul 27.

13.

A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases.

Ducancelle A, Leroy V, Vergniol J, Sturm N, Le Bail B, Zarski JP, Nguyen Khac E, Salmon D, de Ledinghen V, Calès P.

J Clin Gastroenterol. 2017 Aug;51(7):639-649. doi: 10.1097/MCG.0000000000000788.

PMID:
28692443
14.

Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.

Henriet E, Abou Hammoud A, Dupuy JW, Dartigues B, Ezzoukry Z, Dugot-Senant N, Leste-Lasserre T, Pallares-Lupon N, Nikolski M, Le Bail B, Blanc JF, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F.

Hepatology. 2017 Dec;66(6):2016-2028. doi: 10.1002/hep.29336. Epub 2017 Oct 30.

PMID:
28646562
15.

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

Wong VW, Petta S, Hiriart JB, Cammà C, Wong GL, Marra F, Vergniol J, Chan AW, Tuttolomondo A, Merrouche W, Chan HL, Le Bail B, Arena U, Craxì A, de Lédinghen V.

J Hepatol. 2017 Sep;67(3):577-584. doi: 10.1016/j.jhep.2017.05.005. Epub 2017 May 12.

PMID:
28506907
16.

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S; GENTHEP Investigators, Bioulac-Sage P, Letouzé E, Zucman-Rossi J.

Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.

17.

Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies.

Neven B, Pérot P, Bruneau J, Pasquet M, Ramirez M, Diana JS, Luzi S, Corre-Catelin N, Chardot C, Moshous D, Leclerc Mercier S, Mahlaoui N, Aladjidi N, Le Bail B, Lecuit M, Bodemer C, Molina TJ, Blanche S, Eloit M.

Clin Infect Dis. 2017 Jan 1;64(1):83-86. Epub 2016 Oct 6. Erratum in: Clin Infect Dis. 2017 May 1;64(9):1297.

PMID:
27810866
18.

Swelling of the nose and upper lip in a young patient from the Comoro islands.

Desclaux A, Receveur MC, Lechot A, Le Bail B, Malvy D.

Travel Med Infect Dis. 2017 Jan - Feb;15:84-85. doi: 10.1016/j.tmaid.2016.06.012. Epub 2016 Oct 1. No abstract available.

PMID:
27697613
19.

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.

Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Marra F, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Barbara M, Le-Bail B, Arena U, Craxì A, de Ledinghen V.

Hepatology. 2017 Apr;65(4):1145-1155. doi: 10.1002/hep.28843. Epub 2016 Nov 5.

PMID:
27639088
20.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V.

J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2.

PMID:
27151181
21.

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.

de Lédinghen V, Wong GL, Vergniol J, Chan HL, Hiriart JB, Chan AW, Chermak F, Choi PC, Foucher J, Chan CK, Merrouche W, Chim AM, Le Bail B, Wong VW.

J Gastroenterol Hepatol. 2016 Apr;31(4):848-55. doi: 10.1111/jgh.13219.

PMID:
26514665
22.

Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive liver transplantations.

Neau-Cransac M, Le Bail B, Guidicelli G, Visentin J, Moreau K, Quinart A, Boueilh A, Laurent C, Taupin JL.

Transpl Immunol. 2015 Oct;33(2):58-62. doi: 10.1016/j.trim.2015.08.002. Epub 2015 Aug 28.

PMID:
26321506
23.

Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease.

Verdura E, Hervé D, Scharrer E, Amador Mdel M, Guyant-Maréchal L, Philippi A, Corlobé A, Bergametti F, Gazal S, Prieto-Morin C, Beaufort N, Le Bail B, Viakhireva I, Dichgans M, Chabriat H, Haffner C, Tournier-Lasserve E.

Brain. 2015 Aug;138(Pt 8):2347-58. doi: 10.1093/brain/awv155. Epub 2015 Jun 10.

PMID:
26063658
24.

Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio.

Rogier J, Roullet S, Cornélis F, Biais M, Quinart A, Revel P, Bioulac-Sage P, Le Bail B.

Liver Transpl. 2015 May;21(5):690-5. doi: 10.1002/lt.24105.

26.

[Pathology of gallbladder and extrahepatic bile ducts. Case 1. Alcalculous gangrenous cholecystitis].

Le Bail B.

Ann Pathol. 2014 Aug;34(4):271-8. doi: 10.1016/j.annpat.2014.06.006. Epub 2014 Jul 23. French. No abstract available.

PMID:
25132438
27.

[Pathology of gallbladder and extrahepatic bile ducts. Introduction].

Le Bail B.

Ann Pathol. 2014 Aug;34(4):258-65; quiz 269-78. doi: 10.1016/j.annpat.2014.06.008. Epub 2014 Jul 22. Review. French. No abstract available.

PMID:
25132435
28.

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.

Cassinotto C, Lapuyade B, Mouries A, Hiriart JB, Vergniol J, Gaye D, Castain C, Le Bail B, Chermak F, Foucher J, Laurent F, Montaudon M, De Ledinghen V.

J Hepatol. 2014 Sep;61(3):550-7. doi: 10.1016/j.jhep.2014.04.044. Epub 2014 May 9.

PMID:
24815876
29.

Quantification of portal-bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C.

Sandrini J, Boursier J, Chaigneau J, Sturm N, Zarski JP, Le Bail B, de Ledinghen V, Calès P, Rousselet MC.

Mod Pathol. 2014 Jul;27(7):1035-45. doi: 10.1038/modpathol.2013.225. Epub 2014 Jan 3.

30.

Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?

Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-Prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-Sage P.

Histopathology. 2014 May;64(6):890-5. doi: 10.1111/his.12326. Epub 2014 Jan 24.

PMID:
24236804
31.

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.

Wong GL, Vergniol J, Lo P, Wai-Sun Wong V, Foucher J, Le Bail B, Choi PC, Chermak F, Leung KS, Merrouche W, Chan HL, de Lédinghen V.

Ann Hepatol. 2013 Jul-Aug;12(4):570-80.

32.

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD.

Gonzalez C, de Ledinghen V, Vergniol J, Foucher J, Le Bail B, Carlier S, Maury E, Gin H, Rigalleau V.

Int J Endocrinol. 2013;2013:428542. doi: 10.1155/2013/428542. Epub 2013 May 2.

33.

Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.

Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P.

Int J Hepatol. 2013;2013:268625. doi: 10.1155/2013/268625. Epub 2013 Apr 14.

34.

Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context.

Bioulac-Sage P, Sempoux C, Possenti L, Frulio N, Laumonier H, Laurent C, Chiche L, Frédéric Blanc J, Saric J, Trillaud H, Le Bail B, Balabaud C.

Int J Hepatol. 2013;2013:253261. doi: 10.1155/2013/253261. Epub 2013 Apr 18.

35.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR.

J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17.

PMID:
23681425
36.

Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.

Cassinotto C, Lapuyade B, Aït-Ali A, Vergniol J, Gaye D, Foucher J, Bailacq-Auder C, Chermak F, Le Bail B, de Lédinghen V.

Radiology. 2013 Oct;269(1):283-92. doi: 10.1148/radiol.13122208. Epub 2013 Apr 29.

PMID:
23630312
37.

Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.

de Lédinghen V, Vergniol J, Barthe C, Foucher J, Chermak F, Le Bail B, Merrouche W, Bernard PH.

Aliment Pharmacol Ther. 2013 May;37(10):979-88. doi: 10.1111/apt.12307. Epub 2013 Apr 5.

38.

Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens.

Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C.

Int J Hepatol. 2013;2013:417323. doi: 10.1155/2013/417323. Epub 2013 Feb 19.

39.

Hepatic visceral larva migrans presenting as a pseudotumor.

Raffray L, Le Bail B, Malvy D.

Clin Gastroenterol Hepatol. 2013 Jun;11(6):e42. doi: 10.1016/j.cgh.2013.01.030. Epub 2013 Feb 5. No abstract available.

PMID:
23395583
40.

Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.

Bioulac-Sage P, Cubel G, Taouji S, Scoazec JY, Leteurtre E, Paradis V, Sturm N, Nhieu JT, Wendum D, Bancel B, Ramos J, Paraf F, Saint Paul MC, Michalak S, Fabre M, Guettier C, Le Bail B, Zucman-Rossi J, Balabaud C.

Am J Surg Pathol. 2012 Nov;36(11):1691-9. doi: 10.1097/PAS.0b013e3182653ece.

PMID:
23060349
41.

Sorafenib-mediated targeting of the AAA⁺ ATPase p97/VCP leads to disruption of the secretory pathway, endoplasmic reticulum stress, and hepatocellular cancer cell death.

Yi P, Higa A, Taouji S, Bexiga MG, Marza E, Arma D, Castain C, Le Bail B, Simpson JC, Rosenbaum J, Balabaud C, Bioulac-Sage P, Blanc JF, Chevet E.

Mol Cancer Ther. 2012 Dec;11(12):2610-20. doi: 10.1158/1535-7163.MCT-12-0516. Epub 2012 Oct 5.

42.

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B.

Liver Int. 2012 Jul;32(6):911-8. doi: 10.1111/j.1478-3231.2012.02820.x.

PMID:
22672642
43.

Pathology: a pictorial review. A selected atlas of paediatric liver pathology.

Le Bail B.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):248-52. doi: 10.1016/j.clinre.2012.03.030. Epub 2012 May 18.

PMID:
22609293
44.

Double heterozygous germline HNF1A mutations in a patient with liver adenomatosis.

Jeannot E, Lacape G, Gin H, Couchy G, Saric J, Laumonier H, Le Bail B, Bioulac-Sage P, Balabaud C, Zucman-Rossi J.

Diabetes Care. 2012 May;35(5):e35. doi: 10.2337/dc12-0030. No abstract available.

45.

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.

de Lédinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, Le Bail B, Choi PC, Chermak F, Yiu KK, Merrouche W, Chan HL.

J Hepatol. 2012 Apr;56(4):833-9. doi: 10.1016/j.jhep.2011.10.017. Epub 2011 Dec 13.

PMID:
22173167
46.

HLA-DQ genotyping combined with serological markers for the diagnosis of celiac disease: is intestinal biopsy still mandatory?

Clouzeau-Girard H, Rebouissoux L, Taupin JL, Le Bail B, Kalach N, Michaud L, Dabadie A, Olives JP, Blanco P, Morali A, Moreau JF, Lamireau T.

J Pediatr Gastroenterol Nutr. 2011 Jun;52(6):729-33. doi: 10.1097/MPG.0b013e31820a724d.

PMID:
21593645
47.

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V.

Gastroenterology. 2011 Jun;140(7):1970-9, 1979.e1-3. doi: 10.1053/j.gastro.2011.02.058. Epub 2011 Mar 2.

PMID:
21376047
48.

Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.

Castéra L, Bernard PH, Le Bail B, Foucher J, Trimoulet P, Merrouche W, Couzigou P, de Lédinghen V.

Aliment Pharmacol Ther. 2011 Feb;33(4):455-65. doi: 10.1111/j.1365-2036.2010.04547.x.

49.

Lymphoepithelioma-like carcinoma of the ovary: a case report and review of the literature.

Brun JL, Randriambelomanana J, Cherier L, Lafon ME, Trufflandier N, Le Bail B.

Int J Gynecol Pathol. 2010 Sep;29(5):427-31. doi: 10.1097/PGP.0b013e3181db69da. Review.

PMID:
20736767
50.

Gastric variceal bleeding uncovering a rare association of CREST syndrome, primary biliary cirrhosis, nodular regenerative hyperplasia and pulmonary hypertension.

Riviere E, Vergniol J, Reffet A, Lippa N, Le Bail B, de Ledinghen V.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1145-8. doi: 10.1097/MEG.0b013e32833ab83a.

PMID:
20485183

Supplemental Content

Loading ...
Support Center